Cargando…

Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation

Objectives There has been a rapid increase in the number of one- and two-room proton beam therapy (PBT) centers, which may be limited in the number of patients they can treat. The objective of this study was to analyze the impact of the ‘clinical benefit score’ (CBS), utilized as a method for treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ankur M, Khairnar, Rahul, Kowalski, Emily S, Remick, Jill, Nichols, Elizabeth M, Mohindra, Pranshu, Yock, Torunn, Regine, William, Mishra, Mark V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823008/
https://www.ncbi.nlm.nih.gov/pubmed/31720171
http://dx.doi.org/10.7759/cureus.5703
_version_ 1783464456276148224
author Sharma, Ankur M
Khairnar, Rahul
Kowalski, Emily S
Remick, Jill
Nichols, Elizabeth M
Mohindra, Pranshu
Yock, Torunn
Regine, William
Mishra, Mark V
author_facet Sharma, Ankur M
Khairnar, Rahul
Kowalski, Emily S
Remick, Jill
Nichols, Elizabeth M
Mohindra, Pranshu
Yock, Torunn
Regine, William
Mishra, Mark V
author_sort Sharma, Ankur M
collection PubMed
description Objectives There has been a rapid increase in the number of one- and two-room proton beam therapy (PBT) centers, which may be limited in the number of patients they can treat. The objective of this study was to analyze the impact of the ‘clinical benefit score’ (CBS), utilized as a method for treatment prioritization for PBT operating in a ‘cost-neutral’ proton-photon payer environment. Materials & methods This study includes patients considered for PBT at a center that initially had only one or two treatment rooms available for clinical use. Patients were prospectively scored using the CBS, and higher scores were prioritized. The outcome was receipt of PBT and the independent variable was CBS. Crude and adjusted analyses were performed using logistic regression. Results There were 2163 patients evaluated. A total of 205 patients (9.5%) were deemed candidates for PBT, which was received by 122 (5.6%) patients. In patients considered for PBT, the mean CBS was 18.7. Patients who were <21 years old, female, non-Caucasian, receiving re-irradiation, and those with Medicare had a higher CBS. Multivariate analysis adjusting for insurance status revealed both CBS and insurance to be significant predictors for receiving PBT. A unit increase in CBS was associated with 1.04 times increased odds of receiving PBT (OR=1.04, 95%CI: 1.01-1.07, p=0.0145) and having Medicare was associated with 3.13 times increased odds of receiving PBT (OR=3.13, 95%CI: 1.57-6.26, p=0.0012). Subgroup analysis, which only included patients enrolled prior to opening the second gantry, showed 1.05 times increased odds of receiving PBT per unit increase in CBS (OR=1.05, 95%CI: 1.00-1.10, p=0.03) and 2.87 times increased odds of receiving PBT in patients with Medicare (OR=2.87, 95%CI: 1.04-7.92, p=0.04). Conclusion  The CBS utilized was significantly associated with the receipt of PBT in a cost-neutral payer setting. Physicians may consider the use of CBS as a resource allocation tool.
format Online
Article
Text
id pubmed-6823008
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-68230082019-11-12 Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation Sharma, Ankur M Khairnar, Rahul Kowalski, Emily S Remick, Jill Nichols, Elizabeth M Mohindra, Pranshu Yock, Torunn Regine, William Mishra, Mark V Cureus Radiation Oncology Objectives There has been a rapid increase in the number of one- and two-room proton beam therapy (PBT) centers, which may be limited in the number of patients they can treat. The objective of this study was to analyze the impact of the ‘clinical benefit score’ (CBS), utilized as a method for treatment prioritization for PBT operating in a ‘cost-neutral’ proton-photon payer environment. Materials & methods This study includes patients considered for PBT at a center that initially had only one or two treatment rooms available for clinical use. Patients were prospectively scored using the CBS, and higher scores were prioritized. The outcome was receipt of PBT and the independent variable was CBS. Crude and adjusted analyses were performed using logistic regression. Results There were 2163 patients evaluated. A total of 205 patients (9.5%) were deemed candidates for PBT, which was received by 122 (5.6%) patients. In patients considered for PBT, the mean CBS was 18.7. Patients who were <21 years old, female, non-Caucasian, receiving re-irradiation, and those with Medicare had a higher CBS. Multivariate analysis adjusting for insurance status revealed both CBS and insurance to be significant predictors for receiving PBT. A unit increase in CBS was associated with 1.04 times increased odds of receiving PBT (OR=1.04, 95%CI: 1.01-1.07, p=0.0145) and having Medicare was associated with 3.13 times increased odds of receiving PBT (OR=3.13, 95%CI: 1.57-6.26, p=0.0012). Subgroup analysis, which only included patients enrolled prior to opening the second gantry, showed 1.05 times increased odds of receiving PBT per unit increase in CBS (OR=1.05, 95%CI: 1.00-1.10, p=0.03) and 2.87 times increased odds of receiving PBT in patients with Medicare (OR=2.87, 95%CI: 1.04-7.92, p=0.04). Conclusion  The CBS utilized was significantly associated with the receipt of PBT in a cost-neutral payer setting. Physicians may consider the use of CBS as a resource allocation tool. Cureus 2019-09-19 /pmc/articles/PMC6823008/ /pubmed/31720171 http://dx.doi.org/10.7759/cureus.5703 Text en Copyright © 2019, Sharma et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Sharma, Ankur M
Khairnar, Rahul
Kowalski, Emily S
Remick, Jill
Nichols, Elizabeth M
Mohindra, Pranshu
Yock, Torunn
Regine, William
Mishra, Mark V
Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
title Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
title_full Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
title_fullStr Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
title_full_unstemmed Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
title_short Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
title_sort patient prioritization for proton beam therapy in a cost-neutral payer environment: use of the clinical benefit score for resource allocation
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823008/
https://www.ncbi.nlm.nih.gov/pubmed/31720171
http://dx.doi.org/10.7759/cureus.5703
work_keys_str_mv AT sharmaankurm patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT khairnarrahul patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT kowalskiemilys patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT remickjill patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT nicholselizabethm patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT mohindrapranshu patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT yocktorunn patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT reginewilliam patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation
AT mishramarkv patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation